Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update GlobeNewswire November 13, 2025 Announced U.S. Food and Drug Administration (FDA) Acceptance for Reviewof New Drug Application (NDA) for GTx-104 FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal […]

Zacatecas Silver Finalizes Land Access Agreements for Upcoming Drill Program GlobeNewswire November 13, 2025 VANCOUVER, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (TSXV: ZAC; OTC: ZCTSF; FSE: 7TV) is pleased to announce that it has finalized all of the necessary land-access agreements for their upcoming drill program. The company secured the

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments GlobeNewswire November 13, 2025 WILMETTE, Ill., Nov. 13, 2025 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinicalâ€stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced third quarter 2025 financial results and recent developments.

Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights GlobeNewswire November 13, 2025 As the U.S. Food and Drug Administration (FDA) proposed, Clene is concluding analyses of its ALS biomarker data with completion planned shortly The FDA advised Clene to request a Type C meeting to review these further ALS biomarker data analyses

Synergy CHC Corp. Reports Third Quarter 2025 Financial Results and its Eleventh Consecutive Quarter of Profitability GlobeNewswire November 13, 2025 WESTBROOK, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, is announcing its financial results for the three months ended September

New Study from Society of Actuaries Research Institute Dives into Trends and Drivers of Substance-Related Mortality in the U.S. Support Survey Explores Public Awareness of Drug and Alcohol Use GlobeNewswire November 13, 2025 CHICAGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — A study by the Society of Actuaries (SOA) Research Institute found that fentanyl and synthetic

Vivex Biologics Announces Publication of a Real-World Evidence Study Demonstrating Superior or Similar Outcomes for Cygnus(R) Amnion-Based Skin Substitutes in Wound Care GlobeNewswire November 13, 2025 MIAMI, Nov. 13, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, Inc., a leading medical technology company, developing and delivering innovative allografts for musculoskeletal and wound-care applications, today announced the publication

Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 13, 2025 Industry Veteran Bryan Downey Named Chief Commercial Officer NDA Accepted with May 2026 PDUFA Date Commercial Supply Agreement Executed KANSAS CITY, Kan., Nov. 13, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision

Rocklinc Investment Partners Inc. Announces Rocklinc Principled Equity ETF Listing on the TSX GlobeNewswire November 13, 2025 BURLINGTON, Ontario, Nov. 13, 2025 (GLOBE NEWSWIRE) — Rocklinc Investment Partners Inc. (“Rocklinc”) is pleased to announce the listing of units of Rocklinc Principled Equity ETF (the “ETF”) on the Toronto Stock Exchange (“TSX”). Units of the ETF

City of Ottawa's OC Transpo Orders 50 New Flyer Xcelsior(R) Clean-Diesel 60-foot Buses GlobeNewswire November 13, 2025 WINNIPEG, Manitoba, Nov. 13, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) Today, NFI Group Inc.'s (NFI) subsidiary, New Flyer Industries Canada ULC (New Flyer), announced an order from OC Transpo (City of Ottawa) for 50